Skip to main content
GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
4.290
-0.020 (-0.46%)
Nov 21, 2024, 10:54 AM EST - Market open

GoodRx Holdings Revenue

GoodRx Holdings had revenue of $195.25M in the quarter ending September 30, 2024, with 8.50% growth. This brings the company's revenue in the last twelve months to $790.39M, up 7.14% year-over-year. In the year 2023, GoodRx Holdings had annual revenue of $750.27M, down -2.12%.

Revenue (ttm)
$790.39M
Revenue Growth
+7.14%
P/S Ratio
2.13
Revenue / Employee
$1,138,883
Employees
694
Market Cap
1.65B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023750.27M-16.29M-2.12%
Dec 31, 2022766.55M21.13M2.83%
Dec 31, 2021745.42M194.72M35.36%
Dec 31, 2020550.70M162.48M41.85%
Dec 31, 2019388.22M138.70M55.59%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortrea Holdings 2.98B
Clover Health Investments 2.12B
10x Genomics 629.74M
Certara 372.80M
Immunocore Holdings 296.31M
Xencor 85.16M
Nurix Therapeutics 56.42M
Celldex Therapeutics 9.98M
Revenue Rankings

GDRX News

More News